Sandra Gendler

18.2k citations

169 papers · 15.2k indexed · 4 hit papers · h-index 66

Impact in

Immunology top 0.2%
- Immunotherapy and Immune Responses
- Galectins and Cancer Biology
- Immune Cell Function and Interaction
- Reproductive System and Pregnancy
Radiology, Nuclear Medicine and Imaging top 0.2%
- Monoclonal and Polyclonal Antibodies Research

Papers in

Immunology 74
- Immunotherapy and Immune Responses 39
- Galectins and Cancer Biology 20
Radiology, Nuclear Medicine and Imaging 63
- Monoclonal and Polyclonal Antibodies Research 60

Co-authors: Andrew P. Spicer Joyce Taylor‐Papadimitriou Joy Burchell Trevor Duhig Christine L. Hattrup Lucy F. Pemberton Pinku Mukherjee Nigel Peat
Journals: Journal of Biological Chemistry (14 papers)International Journal of Cancer (9 papers)The Journal of Immunology (8 papers)Oncogene (7 papers)Cancer Research (5 papers)
Partner nations: United States United Kingdom Sweden

In The Last Decade

Sandra Gendler

167 papers receiving 14.8k citations

Hit Papers

align trajectories log scale

Structure and Function of the Cell Surface (Tethered) Mucins 2007 · 594 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 Annual Review of Physiology
1995 Annual Review of Physiology
1990 Journal of Biological Chemistry
1983 The Journal of Immunology

Peers

Countries citing papers authored by Sandra Gendler

Since Specialization

Citations

This map shows the geographic impact of Sandra Gendler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Gendler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Gendler more than expected).

Fields of papers citing papers by Sandra Gendler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Gendler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Gendler. The network helps show where Sandra Gendler may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sandra Gendler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sandra Gendler Line = papers co-authored together Sandra Gendler links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Synthesis and Immunological Evaluation of a Multicomponent Cancer Vaccine Candidate Containing a Long MUC1 Glycopeptide ChemBioChem ·Nitin T. Supekar, Vani Lakshminarayanan, Chantelle J. Capicciotti, Anusuya Chinsamy, Cathy S. Madsen, Margreet A. Wolfert, Peter A. Cohen, Sandra Gendler, Geert‐Jan Boons	2017	15
2	Inhibition of Adaptive Immunity by IL9 Can Be Disrupted to Achieve Rapid T-cell Sensitization and Rejection of Progressive Tumor Challenges Cancer Research ·Dominique B. Hoelzinger, Ana Lucía Dominguez, Peter A. Cohen, Sandra Gendler	2014	42
3	Downregulation of Hematopoietic MUC1 during Experimental Colitis Increases Tumor-Promoting Myeloid-Derived Suppressor Cells Clinical Cancer Research ·María Marín-González, Cathy S. Madsen, Damiana Torres, Ronald J. Marler, Jonathan A. Leighton, Peter A. Cohen, Sandra Gendler	2013	17
4	Pancreatic Ductal Adenocarcinoma Mice Lacking Mucin 1 Have a Profound Defect in Tumor Growth and Metastasis Cancer Research ·Dahlia M. Besmer, Jennifer M. Curry, Lopamudra Das Roy, Teresa L. Tinder, Mahnaz Sahraei, Jorge Schettini, Sun‐Il Hwang, Yong Yi Lee, Sandra Gendler, Pinku Mukherjee	2011	110
5	Tri-component MUC1 glycopeptide vaccine induced both humoral and cellular immune responses in MUC1.Tg mice with MMT tumor. (48.20) The Journal of Immunology ·Vani Lakshminarayanan, Pamela Thompson, Margreet A. Wolfert, Judy Bradley, Latha Pathangey, Cathy S. Madsen, Peter A. Cohen, Geert‐Jan Boons, Sandra Gendler	2011	1
6	Core-glycosylated Mucin-like Repeats from MUC1 Are an Apical Targeting Signal Journal of Biological Chemistry ·Carol L. Kinlough, Paul A. Poland, Sandra Gendler, Polly E. Mattila, Iud Karnaningrum, Ora A. Weisz, Rebecca P. Hughey	2011	31
7	Lack of Muc1-Regulated β-Catenin Stability Results in Aberrant Expansion of CD11b+Gr1+ Myeloid-Derived Suppressor Cells from the Bone Marrow Cancer Research ·María Marín-González, Judy Bradley, Pinku Mukherjee, Sandra Gendler	2009	31
8	Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene Oncogene ·Mariela Jaskelioff, Dominique Rivoal, Jian‐Chuan Xia, C Liu, John C. Kramer, Shigeo Koido, Sandra Gendler, Stuart K. Calderwood, Jianlin Gong	2009	18
9	Cutting Edge: Enhanced Pulmonary Clearance of Pseudomonas aeruginosa by Muc1 Knockout Mice The Journal of Immunology ·Wenju Lu, Akinori Hisatsune, Takeshi Koga, Kosuke Kato, Tresa Roebuck Spencer, Erik P. Lillehoj, Wilbur Chen, Alan S. Cross, Sandra Gendler, Andrew T. Gewirtz, K. Chul Kim	2006	116
10	Tyrosines in the MUC1 cytoplasmic tail modulate oncogenic signaling pathways Cancer Research ·Eric J. Thompson, Kandavel Shanmugam, B. N. Lizunov, Christine L. Hattrup, Chen Chen, Judy Bradley, Pinku Mukherjee, Sandra Gendler	2005	2
11	Prevention of Spontaneous Breast Carcinoma by Prophylactic Vaccination with Dendritic/Tumor Fusion Cells The Journal of Immunology ·Jian‐Chuan Xia, Yasuhiro Tanaka, Shigeo Koido, Chunlei Liu, Pinku Mukherjee, Sandra Gendler, Jianlin Gong	2003	67
12	Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1‐positive carcinoma cells Immunology ·Dongshu Chen, Jian‐Chuan Xia, Yasuhiro Tanaka, Hongsong Chen, Shigeo Koido, 嶋崎吉彦, Pinku Mukherjee, Sandra Gendler, Donald Küfe, Jianlin Gong	2003	58
13	MUC1 alters β-catenin-dependent tumor formation and promotes cellular invasion Oncogene ·Joyce A. Schroeder, Melissa C Adriance, Melissa C. Thompson, Todd D. Camenisch, Sandra Gendler	2003	148
14	Induction of Antitumor Immunity by Vaccination of Dendritic Cells Transfected with MUC1 RNA The Journal of Immunology ·Shigeo Koido, Masahiro Kashiwaba, Dongshu Chen, Sandra Gendler, Donald Küfe, Jianlin Gong	2000	151
15	Mice with Spontaneous Pancreatic Cancer Naturally Develop MUC-1-Specific CTLs That Eradicate Tumors When Adoptively Transferred The Journal of Immunology ·Pinku Mukherjee, Lishun Peng, Cathy S. Madsen, Christopher J. Sterner, Melissa C Adriance, Mary J. Tevethia, Sandra Gendler	2000	69
16	Mouse mucin 1 (MUC1) defined by monoclonal antibodies International Journal of Cancer ·Pei Xiang Xing, Diana Alexandra Quijije Molina, Dan Werb, Suha Damag, Sandile, Mauro S. Sandrin, Sandra Gendler, Ian F. C. McKenzie	1998	1
17	Mouse mucin 1 (MUC1) defined by monoclonal antibodies International Journal of Cancer ·Pei Xiang Xing, Diana Alexandra Quijije Molina, Dan Werb, Suha Damag, Sandile, Mauro S. Sandrin, Sandra Gendler, Musfirah Salsabilah	1998	18
18	Abnormal Heart Rate Regulation in GIRK4 Knockout Mice Neuron ·Kevin Wickman, Jan Němec, Sandra Gendler, David E. Clapham	1998	309
19	The epithelial mucin, MUC1, of milk, mammary gland and other tissues Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes ·Stuart Patton, Sandra Gendler, Andrew P. Spicer	1995	236
20	Mucin antigens: Molecular structure and potential use in immunotherapy Joyce Taylor‐Papadimitriou, El–Nasir Lalani, Joy Burchell, Sandra Gendler	1990	1

About Sandra Gendler

Sandra Gendler is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Oncology and Biotechnology, having authored 169 papers that have together received 15.2k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (107 papers), Monoclonal and Polyclonal Antibodies Research (60 papers), Immunotherapy and Immune Responses (39 papers), Galectins and Cancer Biology (20 papers), Carbohydrate Chemistry and Synthesis (14 papers), Cancer Cells and Metastasis (9 papers), Cancer Research and Treatments (8 papers) and Proteoglycans and glycosaminoglycans research (8 papers). The work is most often cited by research in Immunology (5.7k citations), Radiology, Nuclear Medicine and Imaging (3.4k citations), Molecular Biology (9.8k citations), Oncology (3.0k citations) and Cell Biology (1.2k citations). Sandra Gendler has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Andrew P. Spicer, Joyce Taylor‐Papadimitriou, Joy Burchell, Trevor Duhig, Christine L. Hattrup, Lucy F. Pemberton, Pinku Mukherjee, Nigel Peat, El–Nasir Lalani and Gerald J. Rowse. Their work appears in journals such as Journal of Biological Chemistry, International Journal of Cancer, The Journal of Immunology, Oncogene and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact